Clinical Trial Update: Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression [Phase 2]

View source ↗

Summary

The document provides an update on the Phase 2 efficacy study of the investigational drug P276-00 in Cyclin D1-positive malignant melanoma; the trial has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• P276-00 (P276-00)

Snippet

Sponsor: Piramal Enterprises Limited | Conditions: Melanoma | Phase 2 | Status: COMPLETED